Breakthroughs

Follow Breakthroughs
Share on
Copy link to clipboard

Healthcare in the modern world is changing rapidly. To help make sense of today’s challenges and tomorrow’s innovations, Pfizer UK leaders invite a variety of experts from across the pharmaceutical industry, life sciences and patient community to discuss the most pressing healthcare topics. Brought to you by Pfizer Ltd. PP-UNP-GBR-1510 / August 2022

Pfizer


    • Nov 19, 2024 LATEST EPISODE
    • monthly NEW EPISODES
    • 35m AVG DURATION
    • 7 EPISODES


    Search for episodes from Breakthroughs with a specific topic:

    Latest episodes from Breakthroughs

    The vital role of immunisation for disease prevention

    Play Episode Listen Later Nov 19, 2024 33:46


    Dr Ellie Cannon is joined by Sir Jonathan Van-Tam OBE, Former Deputy Chief Medical Officer for England, and Dr Gillian Ellsbury, Primary Care Medical Director at Pfizer UK to discuss the role of vaccination to help prevent infectious diseases and how this can potentially reduce pressures on the NHS.PP-UNP-GBR-10718 / November 2024

    covid-19 health england healthcare vaccines pfizer vaccination nhs breakthroughs pharma infectious diseases vital role disease prevention immunisation
    What sickle cell disease tells us about health inequalities

    Play Episode Listen Later Aug 23, 2024 34:15


    Dr Ellie Cannon is joined by John James OBE, Chief Executive of the Sickle Cell Society and Seema Patel, Specialty Care Medical Director at Pfizer UK, to discuss health inequalities and explore what we can learn from the sickle cell community.PP-UNP-GBR-9699 / August 2024

    health healthcare pfizer chief executives breakthroughs pharma health equity sickle cell sickle cell disease health inequalities sickle cell society
    Understanding the impact of migraine

    Play Episode Listen Later Apr 12, 2024 34:54


    Dr Ellie Cannon is joined by Rob Music, CEO of The Migraine Trust and Gillian Ellsbury, Primary Care Medical Director at Pfizer UK, to explore the impact that migraine has on individuals and wider society.PP-UNP-GBR-8670 / April 2024

    ceo health healthcare breakthrough pfizer headaches breakthroughs migraine
    Innovation in cancer: Defining the future of care

    Play Episode Listen Later Nov 22, 2023 42:58


    Dr Ellie Cannon is joined by Jane Lyons, CEO of Cancer52 and Stefano Podesta, Oncology Lead at Pfizer UK, to discuss the big challenges and opportunities in the fight against cancer within the UK. PP-UNP-GBR-7436 / November 2023

    ceo uk science care innovation cancer healthcare defining pfizer breakthroughs life sciences oncology cancer care fighting cancer
    Delivering a step forward for rare disease patients

    Play Episode Listen Later Sep 13, 2023 30:39


    Dr Ellie Cannon is joined by Dr. Jacqueline Barry, Chief Clinical Officer at the Cell and Gene Therapy Catapult and Owen Marks, Rare Disease Lead at Pfizer UK, to discuss the urgent need to evolve the way rare disease medicines are brought to patients, and why healthcare systems need to keep pace with scientific advancements.PP-UNP-GBR-6142 / August 2023

    science healthcare patients pfizer delivering breakthroughs life sciences healthcare system medicines catapult step forward rare diseases gene therapy chief clinical officer
    Meeting the challenge of Antimicrobial Resistance (AMR)

    Play Episode Listen Later May 10, 2023 36:13


    Dr Ellie Cannon is joined by economist Lord Jim O'Neill (who in 2014 was commissioned to chair a review into the rising increase in drug-resistant infections) and Toby Cousens, Hospital and Internal Medicines Lead at Pfizer UK, to discuss the threat of antimicrobial resistance (AMR) and the challenges it poses both to science and wider society. PP-UNP-GBR-4716 / May 2023

    science healthcare hospitals pfizer infection breakthroughs antibiotics amr superbugs antibiotic resistance antimicrobial resistance
    What can we learn from COVID-19 to address other healthcare challenges?

    Play Episode Listen Later Dec 10, 2022 32:20


    Join Dr Ellie Cannon as she talks to Susan Rienow (Country President, Pfizer UK) and Dr Richard Torbett (CEO, The Association of the British Pharmaceutical Industry) about the lessons learnt from the COVID-19 pandemic and how this could be applied to address other major healthcare challenges.PP-UNP-GBR-2871 / December 2022

    covid-19 pandemic challenges healthcare address pfizer breakthroughs life sciences pharmaceuticals abpi

    Claim Breakthroughs

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel